跳至主要内容
临床试验/CTRI/2024/07/070625
CTRI/2024/07/070625尚未招募4 期

Effects Of Curcumin In Sensorineural Hearing Loss In Patients Having Type 2 Diabetes Mellitus Single Blind Randomized Control Trial

Dr Shanib Ali1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2024年7月24日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
88
试验地点
1
主要终点
1.Magnitude of SNHL in type 2 DM

研究概览

简要总结

Randomized single blinded control trial recruiting 44 patients with type 2 DM  having SNHL.Group A is the test group recieving 500mg tds curcumin for 8 weeks

Group B is control group recieving only standard treatment.Biochemical markers ,haematological investigations ,PTA done at zero day and 8 weeks to compare results

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • PATIENTS WITH DIABETES MELLITUS TYPE 2 AGE 30-60 PATIENTS WITH DOCUMENTED SNHL.

排除标准

  • patients on the insulin therapy HBA1C more than 11% H/O middle ear disease or surgery h/o conductive hearing loss.

结局指标

主要结局

1.Magnitude of SNHL in type 2 DM

时间窗: 8 weeks

2.Evaluate potential of curcumin as therapeutic agent for treating of diabetes associated SNHL

时间窗: 8 weeks

3.Delineate risk factors associated with SNHL among type 2 DM population and serve as a cornerstone in formulating screening guidelinesfor SNHL in type 2 DM

时间窗: 8 weeks

次要结局

  • 1.changes in HBA1c(2 changes in lipid profile)

研究者

发起方
Dr Shanib Ali
申办方类型
Other []
责任方
Principal Investigator
主要研究者

Dr Shanib Ali

Jamia Hamdard University

研究点 (1)

Loading locations...

相似试验